Novo Nordisk Owner to Plow Obesity Drug Profit Into Green Market

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

United States News News

United States United States Latest News,United States United States Headlines

The shareholder that controls Novo Nordisk A/S is responding to a downturn in green assets by ratcheting up investments with profits from the obesity drugmaker.

Crypto Seeks Lifeline in Asia as US Crackdown Spurs More LayoffsCrypto Volatility Picks Up on Looming Sales From FTX’s $3.

4 Billion Token HoardETF Traders Are Pouring Cash Into EM’s Non-China Growth EnginesBitcoin ETFs With a $100 Billion Promise Put Old Funds in DangerCrypto Trading Volume Slumped to Lowest Level of the Year in AugustChina Is Being Left Out by a Record Number of New EM Stock FundsBreach of Microsoft Engineer’s Account Likely Led to Hack of US OfficialsSan Francisco Lost Its Chance to Be Blockchain Capital, Ripple’s Larsen SaysNvidia’s Rally Is Going to Show Traders What a Market Bubble Looks...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in US

United States United States Latest News, United States United States Headlines